CRP and COVID-19: We can speculate that subjects developing a moderate–severe form of COVID-19 maintain a local sub-inflammatory status that could remain localized in the vessels where it is able to maintain an endothelial dysfunction in the middle term, without inducing production of systemic inflammatory markers, such as CRP.